Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors

BCR-ABL1-negative myeloproliferative neoplasms are burdened by a reduced life expectancy mostly due to an increased risk of thrombo-hemorrhagic events, fibrotic progression/leukemic evolution, and infectious complications. In these clonal myeloid malignancies, JAK2V617F is the main driver mutation,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cattaneo, Daniele, Iurlo, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639501/
https://www.ncbi.nlm.nih.gov/pubmed/34867980
http://dx.doi.org/10.3389/fimmu.2021.750346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639501/
https://www.ncbi.nlm.nih.gov/pubmed/34867980
http://dx.doi.org/10.3389/fimmu.2021.750346

Ejemplares similares